AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
12.94
+3.54 (37.66%)
At close: Jan 8, 2025, 4:00 PM
13.18
+0.24 (1.82%)
After-hours: Jan 8, 2025, 7:54 PM EST
AngioDynamics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AngioDynamics stock have an average target of 12, with a low estimate of 10 and a high estimate of 14. The average target predicts a decrease of -7.26% from the current stock price of 12.94.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 10, 2024.
Analyst Ratings
The average analyst rating for AngioDynamics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +8.19% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +8.19% | Oct 4, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | -7.26% | Oct 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +8.19% | Sep 20, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $13 | Strong Buy | Maintains | $18 → $13 | +0.46% | Jul 17, 2024 |
Financial Forecast
Revenue This Year
289.54M
from 303.91M
Decreased by -4.73%
Revenue Next Year
311.82M
from 289.54M
Increased by 7.69%
EPS This Year
-0.41
from -4.59
EPS Next Year
-0.24
from -0.41
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 298.4M | 326.1M | 360.4M | |
| Avg | 289.5M | 311.8M | 350.1M | |
| Low | 277.7M | 294.5M | 336.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.8% | 12.6% | 15.6% | |
| Avg | -4.7% | 7.7% | 12.3% | |
| Low | -8.6% | 1.7% | 7.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.42 | -0.24 | 0.15 | |
| Avg | -0.41 | -0.24 | 0.14 | |
| Low | -0.39 | -0.25 | 0.14 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.